NCT06320782

Brief Summary

The study aims to evaluate the impact of different dietary interventions on body composition (abdominal fat components and quadriceps muscles) and cardiometabolic parameters. This is a randomized clinical trial study conducted in overweight adults, selected by voluntary adherence, in an outpatient clinic of a cardiology hospital. The sample was calculated based on data from a study with the Brazilian population, with the sample size calculated as a function of a mean difference (d) in visceral adipose tissue (VAT) after the interventions, standard deviation (s) and a significance level of 5% (z). To correct eventual losses, the number was increased by 20%. Four dietary interventions will be applied in the 6-month period: group with calorie restriction and balanced distribution of macronutrients (group 1); group with calorie restriction and low-carbohydrate diet (group 2); group with calorie restriction and low-fat diet (group 3) and group with collective nutritional guidance (group 4). Patients will be followed up monthly for the first 6 months to assess weight loss, analyze adherence to the diet therapy plan, reinforce nutritional guidelines, and monitor anthropometric measurements, abdominal adipose tissue, quadriceps muscles, and biochemical parameters. A reassessment will be performed at 12 months to analyze weight regain, analysis of anthropometric measurements, abdominal adipose tissue, quadriceps musculature and biochemical parameters. The evaluation of VAT, subcutaneous adipose tissue (SAT) and quadriceps musculature by ultrasound will be performed at baseline and after 3, 6 and 12 months of intervention. The present study is expected to clarify the effects that different dietary interventions produce over 3, 6 and 12 months on weight, abdominal fat deposits, quadriceps muscles and cardiometabolic parameters.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 23, 2021

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 20, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

3.6 years

First QC Date

January 17, 2024

Last Update Submit

October 14, 2024

Conditions

Keywords

Cardiometabolic Risk FactorsDietetic interventionsAbdominal Obesitysarcopenia

Outcome Measures

Primary Outcomes (3)

  • Thickness, measured in centimeters, of visceral adipose tissue and quadriceps muscles

    The effects that different dietary interventions produce on visceral adipose tissue thickness and quadriceps muscles( measured en centimeters) will be evaluated

    3,6 and 12 months

  • Weight loss measured in kilograms

    The effect of different dietary interventions produce on weight, measured in kilograms, will be evaluated

    6 months

  • Thickness of quadriceps muscle

    Thickness, measured in centimeters, of quadriceps muscle

    3,6 and 12 months

Secondary Outcomes (5)

  • Serum levels of fasting glucose

    6 months

  • Serum levels of Insulin

    6 months

  • Serum levels Triglycerides

    6 months

  • Serum levels Lipid profile

    6 months

  • Serum levels C-reactive protein (hs-CRP)

    6 months

Study Arms (4)

Dietary intervention 1

EXPERIMENTAL

Calorie restriction and balanced distribution of macronutrients

Behavioral: Calorie restriction and balanced distribution of macronutrients

Dietary intervention 2

EXPERIMENTAL

Calorie restriction and low-carbohydrate diet

Behavioral: Calorie restriction and low-carbohydrate diet

Dietary intervention 3

EXPERIMENTAL

Calorie restriction and low-fat diet

Behavioral: Calorie restriction and low-fat diet

Dietary intervention 4

EXPERIMENTAL

Collective nutritional guidance

Behavioral: Collective nutritional guidance

Interventions

Progressive reduction of 500 to 1000 calories from the usual food intake or the recommendation of 20 calories/kg of current weight/day and distribution of macronutrients: 5% of carbohydrates, 2% of proteins and 3% of fats

Dietary intervention 1

Reduction in carbohydrate consumption and an increase in fat and protein intake, with the following proportions: 45% fat, 20% protein and 35% carbohydrate

Dietary intervention 2

Restriction of fat consumption and an increase in carbohydrate consumption, with the following proportions: 20% fat, 15% protein and 65% carbohydrate

Dietary intervention 3

Recommendations of the Food Guide for the Brazilian Population: limitation of the intake of foods with high energy density from fats and simple carbohydrates; substitution of saturated fats for unsaturated fats; exclusion of trans fat from the diet; increasing fruit and vegetable consumption to a daily minimum of 400g; increased consumption of high-fibre foods and limiting the consumption of sugars and salt.

Dietary intervention 4

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals of both sexes, aged ≥20 years, Body Mass Index (BMI) ≥25kg/m², attended at the general Nutrition outpatient clinic of a public university hospital reference in cardiology.

You may not qualify if:

  • Malnourished and eutrophic individuals;
  • Individuals with liver disease and/or splenomegaly, ascites, or with recent abdominal surgery;
  • Pregnant women and women who had children up to 6 months prior to the survey screening;
  • Individuals with consumptive diseases whose weight loss may be a consequence;
  • Individuals with hypothyroidism or hyperthyroidism, on pharmacological therapy for weight loss and/or on hormone therapy;
  • Individuals with mental or psychological illnesses that may make it difficult to understand dietary guidelines;
  • Individuals with physical limitations that made it impossible to carry out the anthropometric and abdominal adipose tissue evaluations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Isa Galvao Rodrigues

Recife, Pernambuco, 51021120, Brazil

Location

Related Publications (1)

  • de Souza RJ, Bray GA, Carey VJ, Hall KD, LeBoff MS, Loria CM, Laranjo NM, Sacks FM, Smith SR. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr. 2012 Mar;95(3):614-25. doi: 10.3945/ajcn.111.026328. Epub 2012 Jan 18.

    PMID: 22258266BACKGROUND

MeSH Terms

Conditions

Obesity, AbdominalHeart DiseasesMetabolic DiseasesMetabolic SyndromeSarcopenia

Interventions

Diet, Carbohydrate-RestrictedDiet, Fat-Restricted

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsCardiovascular DiseasesInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The data analysis and interpretation stage will be carried out by the study coordinator, who will not have knowledge about the allocation of participants among the intervention groups
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: 4 interventions distributed in a randomized manner among 4 different groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 17, 2024

First Posted

March 20, 2024

Study Start

August 23, 2021

Primary Completion

March 26, 2025

Study Completion

December 1, 2025

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations